One-Day depression treatment? new trial puts accelerated TMS to the test

NCT ID NCT07369180

ENROLLING_BY_INVITATION Symptom relief Sponsor: NeuroQore Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a faster version of transcranial magnetic stimulation (TMS) can safely treat major depressive disorder. Instead of the usual 30 sessions over six weeks, participants receive three 19-minute sessions in a single day. The trial includes 37 adults aged 22-85 with drug-resistant depression, comparing active treatment to a sham procedure to measure changes in mood scores.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcranial Magnetic Stimulation (TMS) device
What this could lead to: If it works, this could offer a faster, more convenient treatment option for depression, reducing the need for daily visits over weeks.
What could go wrong: This is a small, early-phase trial with only 37 participants, so results may not apply broadly. The accelerated schedule might not be as effective or safe as the standard regimen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MAJOR DEPRESSIVE DISORDER

Contacts and locations

Locations

LGTC Group

Campbell, California, 95008, United States
LGTC Group

Sunnyvale, California, 94086, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.